Orphazyme A/S ORPH
$ 0.87
-2.25%
Orphazyme A/S Financial Statements 2011-2024 | ORPH
Annual Financial Statements Orphazyme A/S
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
236 M | 1.36 M | 499 K | - | - | - | - | - | - | - |
Shares |
20 M | 20 M | 20 M | - | - | - | - | - | - | - |
Net Income |
-633 M | -337 M | -230 M | -126 M | -57.9 M | -32.6 M | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - |
EBITDA |
-603 M | -335 M | -230 M | -130 M | -62.8 M | -36.6 M | - | - | - | - |
Operating Expenses |
- | 336 M | 232 M | 131 M | 63.5 M | 37.1 M | - | - | - | - |
General and Administrative Expenses |
342 M | 23.8 M | 19.2 M | 32 M | 5.27 M | 5.49 M | - | - | - | - |
All numbers in USD currency